Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

• DOI: 10.1016/j.ejca.2024.114305
• Publication Date: 2024-09-03T16:38:54Z
• Authors: Mario Mandalà; Andrea Ferrari; Ines B. Brecht; Karijn PM Suijker...; Linda Maschke; Diana Giannarelli; Alice Indini; Martina Ubaldi; Giulia Pecci; Victoria Atkinson; Hildur Helgadottir; Stefano Chiaravalli; Naima Benannoune; Caroline Robert; Pawel Teterycz; Piotr Rutkowski; Susana Puig; Gabriele Madonna; Rejin Kebudi; Shirly Grynberg; Lidia MRB Arantes; Ewa Bien; Malgorzata Krawczyk; Maria Debora De P...; Miranda P. Dierse...; Daniela Massi; Georgina V. Long; Paolo Antonio Asc...; Alexander M.M. Eg...
• Keywords: Antibody therapy

Data on the efficacy and safety of anti PD-1 antibodies in children adolescents (CA) with melanoma are lacking. The aim this study was to determine outcomes CA patients receiving antibodies.